Abrdn Life Sciences Investors Share Price & Technical Analysis
HQL · $17.34 (+0.87%)
Financial Services / Asset Management
$17.34
+0.87%
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, d…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-2% return in May, -2% avg return in past 3 year May month.
3% return in 2026, 8% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 1% | -2% | -1% | 7% | -2% | – | – | – | – | – | – | – | 3% |
| 25 | 8% | -5% | -6% | 2% | -5% | 4% | 2% | 6% | 12% | 15% | 3% | -5% | 30% |
| 24 | 1% | -1% | -1% | -4% | 2% | 7% | 8% | -3% | 0% | -3% | -1% | -8% | -2% |
| 23 | 4% | -6% | 0% | 0% | -4% | 2% | -1% | -3% | -5% | -7% | 3% | 13% | -4% |
| 22 | -6% | -9% | 1% | -7% | -5% | -3% | 5% | -3% | -5% | 6% | 2% | -6% | -30% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Emerging · Neutral
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$549.17M
P/E ratio
6.47
52W high
$18.46
52W low
$12.12
Volume
88,292
Beta
0.74
Related stocks in Financial Services
Citigroup Inc Cedear Eac…
₹62,000
Berkshire Hathaway Inc C…
₹32,260
American Express Co Cede…
₹30,760
Visa Inc Cedears (each 1…
₹26,585
Coinbase Global Inc Ced …
₹11,800
Frequently asked questions
- What is Abrdn Life Sciences Investors share price today?
- Abrdn Life Sciences Investors (HQL) last traded around $17.34 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does HQL have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for HQL. Download the app for real-time alerts.
- How can I analyze Abrdn Life Sciences Investors stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.